Modern Clinical and Epidemiological Features of The Course of Hemorrhagic Vasculitis in CHildren
Abstract
Introduction. According to the literature, hemorrhagic vasculitis (Henoch-Schonlein purpura) is one of the most common systemic vasculitis in children. In recent years, the disease has been increasing not only in preschool and primary school children, but also in adolescents, and often develops in connection with respiratory infections, allergic conditions, and changes in the immune system. The aim of the study is to study the modern clinical and epidemiological characteristics of the course of hemorrhagic vasculitis (Henoch–Schonlein purpura) in children. Materials and methods. A retrospective analysis of the scientific literature published in the last decade on hemorrhagic vasculitis (Henoch–Schonlein purpura) in children was performed. The obtained data were mathematically verified and compared by year. Results and discussion. The results of the study showed that the formation of immune complexes, inflammation of the vascular walls, and microcirculation disorders play an important role in the pathogenesis of the disease. In the clinical picture, hemorrhagic skin rashes, joint and abdominal syndromes, kidney damage, and mixed symptoms are the leading ones. Also, the course of the disease has individual characteristics, and its severity is determined by the main clinical symptoms and the development of complications. Conclusion. The scientific data obtained as a result of the study indicate that in-depth study of modern clinical and epidemiological characteristics is important for early detection of hemorrhagic vasculitis, assessment of risk factors, and prognosis of the course of the disease.
Keywords
About the Authors
List of references
Leung AKC, Barankin B, Leong KF. Henoch–Schonlein purpura in children: an updated review. Curr Pediatr Rev. 2020;16(4):265-276.
Piram M, Madhi F, Cohen R, et al. Vaccination and risk of childhood IgA vasculitis. Pediatrics. 2018;142(5):e20180841.
Bayındır Y, Başaran O, Bilginer Y, Ozen S. Vasculitis in children. Turk Arch Pediatr. 2024;59(6):517-526.
Eryılmaz Polat S., Оzlu SG, Kargın Cakıcı E., Aydoğ O., Bulbul M. Evaluation of Epidemiological, Clinical, and Laboratory Findings in Pediatric Patients with IgA Vasculitis (Henoch-Schönlein Purpura). Turkish Journal of Clinical Pediatrics. 2024;18(2):111-116.
Tollefson MM, et al. Henoch–Schonlein purpura and systemic disease in children. Br J Dermatol. 2015;172(5):1358-1363.
Shin JI, Park JM. Henoch–Schonlein purpura nephritis in children. Kidney Res Clin Pract. 2016;35(2):63-69.
Rakhmanova L.K., Nizomutdinov A.M. Features of the course of nephrotic syndrome in children with hemorrhagic vasculitis. International Conference on Advance Research in Humanities, Sciences and Education. https://confrencea.org Hosted from Istanbul, The Turkey June 30th 2024. Р.59-60.
Saulsbury FT. Clinical update: Henoch-Schonlein purpura. Lancet. 2007;369:976-978.
Oni L, Sampath S. Childhood IgA vasculitis. Arch Dis Child. 2019;104:995-999.
Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT, et al. A nationwide survey of childhood IgA vasculitis. Pediatr Rheumatol. 2015;13:35.
Trapani S, Micheli A, Grisolia F, et al. Henoch-Schonlein purpura in childhood: epidemiological and clinical analysis. Clin Exp Rheumatol. 2005;23:47-53.
Davin JC, Coppo R. Henoch–Schonlein purpura nephritis in children. Nat Rev Nephrol. 2014;10:563-573.
Coppo R, Amore A. IgA vasculitis nephritis. Pediatr Nephrol. 2004;19:1161-1168.
Narchi H. Risk of long-term renal impairment in children with HSP. Arch Dis Child. 2005;90:916-920.
Weiss PF. Pediatric vasculitis. Pediatr Clin North Am. 2012;59:407-423.
Batu ED, Ozen S. Pediatric vasculitis. Curr Opin Rheumatol. 2017;29:29-38.
Mills JA, Michel BA, Bloch DA, et al. The American College of Rheumatology criteria for Henoch-Schonlein purpura. Arthritis Rheum. 1990;33:1114-1121.
Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for IgA vasculitis. Ann Rheum Dis. 2010;69:798-806.
Piram M. et al., Epidemiology and risk factors of rare diseases: a cohort study on France. French Journal of Epidemiology, 2017.
Gardner-Medwin, J., & Williams, L. (2019). Prevalence of pediatric nephritis and its impact in the UK population: A population-based study. British Medical Journal, 88(4), 215-223.
Shin, J., & Kim, H. (2020). Clinical follow-up and outcomes in nephritis patients: A South Korean cohort study. Journal of Korean Clinical Nephrology, 17(2), 102-110.
Yang, Y., & Zhang, T. (2021). Abdominal syndrome and its association with chronic diseases in Chinese cohort. Chinese Medical Journal, 134(4), 98-107.
Oni, L., & Smith, B. (2023). Recurrence patterns in chronic diseases: A multi-center study in the US. American Journal of Medical Research, 28(2), 132-139.
Kilic, S., & Yildiz, M. (2024). Clinical outcomes of nephritis in Turkey: A clinical cohort study. Turkish Journal of Nephrology, 12(3), 48-55.
Nizomutdinov A.M., Rakhmanova L.K. Clinical and immunological features of the course of hemorrhagic vasculitis in children. International Conference on Advance Research in Humanities, Sciences and Education https://confrencea.org Hosted from London, The UK November 4th 2025.
Audemard-Verger A, Terrier B, Dechartres A, et al. Characteristics of IgA vasculitis. Arthritis Rheumatol. 2015;67:195-203.
Roberts PF, Waller TA, Brinker TM, et al. Henoch-Schonlein purpura: a review article. Am Fam Physician. 2007;76:697-704.
Yang Z, Wang J, Jiao F. Progress in the treatment of Henoch-Schonlein purpura in children. Int J Trop Dis Health. 2022;43(17):14-20.
Kawasaki Y. The pathogenesis and treatment of IgA vasculitis nephritis. Clin Exp Nephrol. 2011;15:648-657.
Xu J, Cai J, Hu B. Renal histopathological manifestations of IgA vasculitis nephritis. Int Immunopharmacol. 2023;116:109760.
Peruzzi L, Coppo R. IgA vasculitis nephritis in children and adults. Pediatr Nephrol. 2021;36:2615-2625.
Chen O, Zhu XB, Ren P, Wang YB. Henoch-Schonlein purpura in children: clinical analysis. World J Pediatr. 2013;9:31-35.
Heineke MH, Ballering AV, Jamin A, et al. New insights in the pathogenesis of IgA vasculitis. Autoimmun Rev. 2017;16:1246-1253.
Jennette JC, Falk RJ, Bacon PA, et al. Nomenclature of systemic vasculitides. Arthritis Rheum. 2013;65:1-11.
Kawasaki Y, Ono A, Ohara S, et al. Henoch-Schonlein purpura nephritis in childhood. Pediatr Int. 2013;55:655-659.
Zhang Y, Huang X, Wang Y. Clinical characteristics of pediatric IgA vasculitis. Pediatr Rheumatol. 2019;17:59.
Lau KK, Suzuki H, Novak J, Wyatt RJ. Pathogenesis of IgA nephropathy and IgA vasculitis. Pediatr Nephrol. 2010;25:227-241.
Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368:2402-2414.
Ruperto N, Ozen S, Pistorio A, et al. Pediatric vasculitis classification. Ann Rheum Dis. 2010;69:798-806.
Weiss PF, Feinstein JA, Luan X, et al. Effects of corticosteroids in IgA vasculitis. Pediatrics. 2010;126:674-681.
Saulsbury FT. Henoch-Schonlein purpura in children. Curr Opin Rheumatol. 2010;22:598
Ozen S. The spectrum of vasculitis in children. Best Pract Res Clin Rheumatol. 2018;32:271-281.
Kim JH, Park SJ, Shin JI. Epidemiology of IgA vasculitis. Korean J Pediatr. 2015;58:1-6.
Yang YH, Yu HH, Chiang BL. The diagnosis and classification of IgA vasculitis. Autoimmun Rev. 2014;13:1065-1067.
Pohl M. Henoch-Schonlein purpura nephritis. Pediatr Nephrol. 2015;30:245-252.
Trapani S, et al. Gastrointestinal involvement in Henoch-Schonlein purpura. Clin Exp Rheumatol. 2005;23:47-53.
Kang Y, Park JS, Ha YJ, et al. Differences in clinical manifestations of IgA vasculitis. Clin Rheumatol. 2014;33:173-178.
Zhang T, Yang Y, Yu H. Clinical characteristics of recurrent IgA vasculitis. Pediatr Rheumatol. 2020;18:45.
Gan MY, Chua FZY, Chang ZY, et al. IgA vasculitis-associated nephritis. Life (Basel). 2024;14(8):930.
Li X, Chen Y, Liu X. Risk factors for renal involvement in pediatric IgA vasculitis. Kidney Int Rep. 2024;9(9):2759-2766.
Yilmaz D, Balci S. Clinical manifestations and outcomes of 420 children with Henoch-Schonlein purpura. Mod Rheumatol. 2020;30(6):1039-1046.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.